Pioneer Trust Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,350
Closed -$286K 73
2021
Q1
$286K Hold
3,350
0.08% 60
2020
Q4
$316K Hold
3,350
0.1% 58
2020
Q3
$291K Hold
3,350
0.1% 59
2020
Q2
$293K Hold
3,350
0.11% 57
2020
Q1
$276K Hold
3,350
0.13% 59
2019
Q4
$317K Hold
3,350
0.12% 63
2019
Q3
$291K Hold
3,350
0.12% 64
2019
Q2
$306K Sell
3,350
-723
-18% -$61.2K 0.13% 64
2019
Q1
$351K Sell
4,073
-112
-3% -$8.99K 0.15% 62
2018
Q4
$322K Hold
4,185
0.16% 63
2018
Q3
$323K Sell
4,185
-558
-12% -$41.3K 0.14% 61
2018
Q2
$321K Sell
4,743
-87
-2% -$6K 0.15% 67
2018
Q1
$350K Hold
4,830
0.18% 59
2017
Q4
$364K Hold
4,830
0.18% 61
2017
Q3
$371K Buy
+4,830
New +$365K 0.19% 62
2015
Q4
Sell
-2,463
Closed -$203K 76
2015
Q3
$203K Hold
2,463
0.14% 70
2015
Q2
$217K Hold
2,463
0.14% 66
2015
Q1
$217K Sell
2,463
-87
-3% -$7.72K 0.14% 72
2014
Q4
$212K Sell
2,550
-446
-15% -$37K 0.14% 68
2014
Q3
$252K Hold
2,996
0.17% 62
2014
Q2
$243K Hold
2,996
0.17% 60
2014
Q1
$228K Sell
2,996
-20,765
-87% -$1.51M 0.16% 61
2013
Q4
$1.71M Sell
23,761
-206
-0.9% -$14.3K 1.21% 35
2013
Q3
$1.65M Hold
23,967
1.26% 34
2013
Q2
$1.52M Buy
+23,967
New +$1.56M 1.18% 34

Other funds holding NVS

Pioneer Trust Bank's NVS Position: Q2 2021 in Review

Pioneer Trust Bank sold out of Novartis (NVS) in Q2 2021, closing a stake of 3,350 shares — an estimated $286K sold.

Pioneer Trust Bank first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $1.71M in Q4 2013. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

  • Pioneer Trust Bank reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
  • Pioneer Trust Bank sold 3,350 Novartis shares in Q2 2021, an estimated $286K.
  • Pioneer Trust Bank first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
  • Pioneer Trust Bank's Novartis position peaked at $1.71M in Q4 2013.
  • 1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Pioneer Trust Bank's 13F filing for Q2 2021, filed 19 Jul 2021.